Published in Am J Physiol on January 01, 1994
Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest (1997) 1.60
NO and KATP channels underlie endotoxin-induced smooth muscle hyperpolarization in rat mesenteric resistance arteries. Br J Pharmacol (2004) 0.91
Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null mice. Am J Pathol (2007) 0.87
Neuropeptide Y overflow and metabolism in skeletal muscle arterioles. J Physiol (2011) 0.87
Temporal variation in endotoxin-induced vascular hyporeactivity in a rat mesenteric artery organ culture model. Br J Pharmacol (2001) 0.85
ATP overflow in skeletal muscle 1A arterioles. J Physiol (2010) 0.85
Influence of estradiol supplementation on neuropeptide Y neurotransmission in skeletal muscle arterioles of F344 rats. Am J Physiol Regul Integr Comp Physiol (2012) 0.76
The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA (1996) 3.09
Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol (1990) 2.83
Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J (1999) 2.75
Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem Pharmacol (1986) 2.04
Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol (2007) 1.91
Development of spontaneous manding in language deficient children. J Appl Behav Anal (1980) 1.87
Prompting and stimulus shaping procedures for teaching visual-motor skills to retarded children. J Appl Behav Anal (1984) 1.65
Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol (2007) 1.60
Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene (1999) 1.55
Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry (1999) 1.53
Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun (1990) 1.53
Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol (1997) 1.41
Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol (2000) 1.25
The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol (1991) 1.23
A human tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J (2001) 1.23
Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension (2001) 1.19
Quality of life and psychosocial adjustment of young patients after treatment of bone cancer. Cancer (1998) 1.19
Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr (1998) 1.19
Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol (1991) 1.19
Prevention of thromboses in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a monospecific antivenom. Research Group on Snake Bites in Martinique. Am J Trop Med Hyg (1995) 1.14
Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. Eur J Pharmacol (1991) 1.13
Mutations of phage P22 affecting phage DNA synthesis and lysogenization. J Mol Biol (1971) 1.13
Calcium handling and purinoceptor subtypes involved in ATP-induced contraction in rat small mesenteric arteries. J Physiol (1996) 1.13
Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.12
Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the alpha-adrenoceptor agonist B-HT 920 in rat isolated aorta. Br J Pharmacol (1984) 1.11
The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J Biol Chem (2001) 1.11
Immunomodulatory effects of acupuncture in the treatment of allergic asthma: a randomized controlled study. J Altern Complement Med (2000) 1.11
Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol (1991) 1.09
Peer tutoring with or without home-based reinforcement, for reading remediation. J Appl Behav Anal (1980) 1.08
Prognostic significance of clinical grading of patients envenomed by Bothrops lanceolatus in Martinique. Members of the Research Group on Snake Bite in Martinique. Trans R Soc Trop Med Hyg (1999) 1.07
Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res (2000) 1.05
Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Biochem Pharmacol (1987) 1.05
Participation of endothelium-derived relaxing factor and role of cyclic GMP in inhibitory effects of endothelium on contractile responses elicited by alpha-adrenoceptor agonists in rat aorta. J Cardiovasc Pharmacol (1991) 1.04
Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS. Br J Pharmacol (1995) 1.04
Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Br J Pharmacol (1992) 1.01
Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity. Biochem Biophys Res Commun (1983) 0.99
Dependence of endotoxin-induced vascular hyporeactivity on extracellular L-arginine. Br J Pharmacol (1993) 0.98
Inhibition by papaverine of cGMP and cAMP phosphodiesterases from the rat heart. Biochem Pharmacol (1974) 0.98
L-arginine induces relaxation of small mesenteric arteries from endotoxin-treated rats. Eur J Pharmacol (1992) 0.97
Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. J Cardiovasc Pharmacol (1999) 0.97
Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction. J Cardiovasc Pharmacol (1990) 0.96
Dissociation between endothelium-mediated increases in tissue cGMP levels and modulation of aortic contractile responses. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.96
Spatial dynamics of farming practices in the Seine basin: methods for agronomic approaches on a regional scale. Sci Total Environ (2007) 0.96
Positive practice overcorrection: the effects of duration of positive practice on acquisition and response reduction. J Appl Behav Anal (1983) 0.95
Alteration by lipopolysaccharide of the relationship between intracellular calcium levels and contraction in rat mesenteric artery. Br J Pharmacol (1996) 0.95
Evidence for N-acetylcysteine-sensitive nitric oxide storage as dinitrosyl-iron complexes in lipopolysaccharide-treated rat aorta. Br J Pharmacol (1996) 0.94
Calmodulin and its role in intracellular calcium regulation. Prog Neurobiol (1987) 0.94
An ubiquitous protein which regulates calcium-dependent cellular functions and calcium movements. Biochem Pharmacol (1981) 0.93
Bepridil and flunarizine as calmodulin inhibitors. Eur J Pharmacol (1984) 0.93
Radiation doses of Swiss population from external sources. J Environ Radioact (2002) 0.93
Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med (1992) 0.93
Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online. Hum Mutat (1999) 0.92
Effects of cGMP on calcium handling in ATP-stimulated rat resistance arteries. Am J Physiol (1995) 0.92
Mechanism of Ca2+ release and entry during contraction elicited by norepinephrine in rat resistance arteries. Am J Physiol (1999) 0.92
Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries. Br J Pharmacol (1997) 0.91
Endotoxin-induced impairment of vascular smooth muscle contractions elicited by different mechanisms. Eur J Pharmacol (1990) 0.91
Hyporeactivity of mesenteric vascular bed in endotoxin-treated rats. Eur J Pharmacol (1996) 0.91
Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase. Experientia (1978) 0.90
Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel. Br J Pharmacol (1992) 0.90
Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation (1999) 0.90
Age-related decrease of in vitro isoproterenol-induced cyclic AMP accumulation in rat aorta. Eur J Pharmacol (1982) 0.90
Alterations in calcium stores in aortic myocytes from spontaneously hypertensive rats. Hypertension (1997) 0.90
Alterations of cyclo-oxygenase products and NO in responses to angiotensin II of resistance arteries from the spontaneously hypertensive rat. Br J Pharmacol (1996) 0.89
Nitric oxide-related cyclic GMP-independent relaxing effect of N-acetylcysteine in lipopolysaccharide-treated rat aorta. Br J Pharmacol (1998) 0.89
Thrombotic stroke following snake bites by the "Fer-de-Lance"Bothrops lanceolatus in Martinique despite antivenom treatment: a report of three recent cases. Toxicon (2006) 0.89
Characterisation of cyclic nucleotide phosphodiesterases from rat mesenteric artery. Eur J Pharmacol (1991) 0.88
Insensitivity of calcium-dependent endothelial stimulation in rat isolated aorta to the calcium entry blocker, flunarizine. Br J Pharmacol (1985) 0.88
A 16 kDa protein substrate for protein kinase C and its phosphorylation upon stimulation of vasopressin receptors in rat aortic myocytes. Biochem Biophys Res Commun (1987) 0.88
Functional characterization of postjunctional alpha-adrenoceptors in rat aorta. Eur J Pharmacol (1981) 0.88
[Epidural injection therapy with local anaesthetics versus cortisone in the lumbar spine syndrome: a prospective study]. Z Orthop Unfall (2009) 0.87
Identifying the educative and suppressive effects of positive practice and restitutional overcorrection. J Appl Behav Anal (1981) 0.87
Cyclic nucleotide phosphodiesterase inhibition and vascular smooth muscle relaxation. Eur J Pharmacol (1972) 0.87
Exogenous NG-hydroxyl-L-arginine causes nitrite production in vascular smooth muscle cells in the absence of nitric oxide synthase activity. FEBS Lett (1994) 0.87
[Does cyclic AMP play a part in the bronchodilator effect of theophylline? (author's transl)]. Bull Eur Physiopathol Respir (1980) 0.86
Effect of dexamethasone on the onset and persistence of vascular hyporeactivity induced by E. coli lipopolysaccharide in rats. Circ Shock (1993) 0.86
Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries. Br J Pharmacol (1988) 0.86
Comparison of cyclic nucleotide phosphodiesterase isoforms from rat heart and bovine aorta. Separation and inhibition by selective reference phosphodiesterase inhibitors. Biochem Pharmacol (1988) 0.86
A pertussis toxin-insensitive calcium influx mediated by neuropeptide Y2 receptors in a human neuroblastoma cell line. J Biol Chem (1994) 0.86
Involvement of protein kinase C, tyrosine kinases, and Rho kinase in Ca(2+) handling of human small arteries. Am J Physiol Heart Circ Physiol (2000) 0.86
Beta-endorphin-sensitive opioid receptors in the rat tail artery. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.85
Effect of distance between sites and region of the body on results of skin prick tests. J Allergy Clin Immunol (1996) 0.85
Influence of endothelium on induction of the L-arginine-nitric oxide pathway in rat aortas. Am J Physiol (1993) 0.85
Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles. Eur J Pharmacol (1992) 0.85
Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria. J Cardiovasc Pharmacol (1990) 0.85
Pharmacological approaches of endothelial nitric oxide-dependent vasorelaxation induced by polyphenols from plant extracts. Methods Enzymol (1999) 0.85
Cholesterol content drives distinct pharmacological behaviours of micro-opioid receptor in different microdomains of the CHO plasma membrane. Mol Membr Biol (2008) 0.85